These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19020786)

  • 1. Evaluation of urgency in women, with a validated Urgency, Severity and Impact Questionnaire (USIQ).
    Lowenstein L; FitzGerald MP; Kenton K; Hatchett L; Durazo-Arvizu R; Mueller ER; Goldman K; Brubaker L
    Int Urogynecol J Pelvic Floor Dysfunct; 2009 Mar; 20(3):301-7. PubMed ID: 19020786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and responsiveness of the Urgency Severity and Life Impact Questionnaire (USIQ).
    Lowenstein L; Rickey L; Kenton K; Fitzgerald MP; Brubaker L; Tulke M; Fordham J; Mueller ER
    Int Urogynecol J; 2012 Feb; 23(2):193-6. PubMed ID: 21850507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
    Lai H; Gardner V; Vetter J; Andriole GL
    BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The validation of the Dutch OAB-q SF: An overactive bladder symptom bother and health-related quality of life short-form questionnaire.
    Groenendijk IM; Scheepe JR; Noordhoff TC; Blok BFM
    Neurourol Urodyn; 2019 Aug; 38(6):1775-1782. PubMed ID: 31215693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimum important difference for validated instruments in women with urge incontinence.
    Dyer KY; Xu Y; Brubaker L; Nygaard I; Markland A; Rahn D; Chai TC; Stoddard A; Lukacz E;
    Neurourol Urodyn; 2011 Sep; 30(7):1319-24. PubMed ID: 21563210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of baseline severity of lower urinary tract symptoms with the success conservative therapy for urinary incontinence in women.
    Obloza A; Teo R; Marriott E; Parker G; Tincello D
    Int Urogynecol J; 2019 May; 30(5):705-710. PubMed ID: 30306193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of the Polish version of the Urogenital Distress Inventory short form and the Incontinence Impact Questionnaire short form.
    Skorupska KA; Miotla P; Kubik-Komar A; Skorupski P; Rechberger T
    Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():171-174. PubMed ID: 28633095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.
    Kubota Y; Kojima Y; Shibata Y; Imura M; Kohri K; Sasaki S
    Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic and psychological triggers for bladder storage symptoms among men and women.
    Zilberlicht A; Boms-Yonai N; Haya N; Feferkorn I; Lavie O; Abramov Y
    Int Urogynecol J; 2020 May; 31(5):933-937. PubMed ID: 31165217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of symptom bother and health-related quality of life in Japanese female patients with overactive bladder.
    Gotoh M; Kobayashi T; Sogabe K
    Neurourol Urodyn; 2015 Nov; 34(8):730-5. PubMed ID: 25212503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of overactive bladder on quality of life and resource use: results from Korean Burden of Incontinence Study (KOBIS).
    Lee KS; Choo MS; Seo JT; Oh SJ; Kim HG; Ng K; Lee KJ; Tan JT; Kim JC
    Health Qual Life Outcomes; 2015 Jun; 13():89. PubMed ID: 26113125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of the Polish version of the Overactive Bladder Symptom Score (OABSS) questionnaire : Correlation of the OABSS with urodynamic study and the UDI-6 and IIQ-7 questionnaires.
    Wróbel A; Skorupska K; Rechberger E; Woźniak A; Miotla P; Kubik-Komar A; Skorupski P; Rechberger T
    Int Urogynecol J; 2019 Dec; 30(12):2135-2139. PubMed ID: 31396639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of stress and urgency urinary incontinence and its effect on quality of life.
    Minassian VA; Sun H; Yan XS; Clarke DN; Stewart WF
    Int Urogynecol J; 2015 Feb; 26(2):269-76. PubMed ID: 25278207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the transobturator tape procedure on overactive bladder symptoms and quality of life: a prospective study.
    Polat S; Yonguc T; Yarimoglu S; Bozkurt IH; Sefik E; Degirmenci T
    Int Braz J Urol; 2019; 45(6):1186-1195. PubMed ID: 31808407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q.
    Coyne K; Revicki D; Hunt T; Corey R; Stewart W; Bentkover J; Kurth H; Abrams P
    Qual Life Res; 2002 Sep; 11(6):563-74. PubMed ID: 12206577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M; Crampton J
    Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining urinary urgency: patient descriptions of "gotta go".
    Coyne KS; Harding G; Jumadilova Z; Weiss JP
    Neurourol Urodyn; 2012 Apr; 31(4):455-9. PubMed ID: 22275170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
    Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
    BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.